Literature DB >> 19809485

Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis.

Kirsten F L Douma1, Neil K Aaronson, Hans F A Vasen, Senno Verhoef, Chad M Gundy, Eveline M A Bleiker.   

Abstract

Childhood DNA testing, prenatal diagnosis (PND) and preimplantation genetic diagnosis (PGD) are available for familial adenomatous polyposis (FAP). However, the use of PND and PGD is controversial. The purpose of this study was to investigate attitudes toward, and experiences with, childhood DNA testing, PND and PGD among members of families at high risk for FAP. In this nationwide, cross-sectional study, questionnaires were sent to individuals from families at high risk for FAP assessing attitudes toward and experiences with childhood testing, PND and PGD, as well as several sociodemographic, clinical and psychosocial variables. Of the individuals from FAP families invited to participate in the study, 525 members participated (response rate=64%). Most parents who had children who were minors (n=93) (82%) were satisfied with the DNA testing procedure. One-third of all individuals wanted DNA testing for their children before age 12. Forty percent of FAP patients indicated that the disease influenced their desire to have children. Only 15% considered termination of pregnancy for FAP acceptable. Approximately 30% of individuals with a FAP diagnosis and their partners considered PND and PGD as acceptable for themselves. A positive attitude was associated with higher levels of guilt and a positive attitude toward termination of pregnancy. Importantly, of those with FAP at childbearing age, 84% had had no previous information at all about either PND or PGD. Future efforts should be aimed at educating FAP family members about reproductive options, allowing them to make an informed choice about family planning. Routine discussion of all reproductive options with a medical specialist should be encouraged.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19809485      PMCID: PMC2987203          DOI: 10.1038/ejhg.2009.151

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  24 in total

1.  Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands.

Authors:  L N Lodder; P G Frets; R W Trijsburg; E J Meijers-Heijboer; J G Klijn; M F Niermeijer
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

2.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

Authors:  N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  Family history of breast cancer: what do women understand and recall about their genetic risk?

Authors:  M Watson; V Duvivier; M Wade Walsh; S Ashley; J Davidson; M Papaikonomou; V Murday; N Sacks; R Eeles
Journal:  J Med Genet       Date:  1998-09       Impact factor: 6.318

4.  Preimplantation genetic diagnosis of inherited cancer: familial adenomatous polyposis coli.

Authors:  A Ao; D Wells; A H Handyside; R M Winston; J D Delhanty
Journal:  J Assist Reprod Genet       Date:  1998-03       Impact factor: 3.412

5.  Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis.

Authors:  Fay Kastrinos; Elena M Stoffel; Judith Balmaña; Sapna Syngal
Journal:  Am J Gastroenterol       Date:  2007-03-13       Impact factor: 10.864

6.  Attitudes to predictive DNA testing in familial adenomatous polyposis.

Authors:  S Whitelaw; J M Northover; S V Hodgson
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

7.  Preimplantation genetic diagnosis: patients' experiences and attitudes.

Authors:  S A Lavery; R Aurell; C Turner; C Castello; A Veiga; P N Barri; R M Winston
Journal:  Hum Reprod       Date:  2002-09       Impact factor: 6.918

8.  Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.

Authors:  Ashley D Staton; Allison W Kurian; Kristin Cobb; Meredith A Mills; James M Ford
Journal:  Fam Cancer       Date:  2007-11-17       Impact factor: 2.375

9.  Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment.

Authors:  S Adam; S Wiggins; P Whyte; M Bloch; M H Shokeir; H Soltan; W Meschino; A Summers; O Suchowersky; J P Welch
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

10.  Prenatal testing for late-onset diseases such as mutations in the breast cancer gene 1 (BRCA1). Just a choice or a step in the wrong direction?

Authors:  T M Wagner; R Ahner
Journal:  Hum Reprod       Date:  1998-05       Impact factor: 6.918

View more
  15 in total

1.  Performing and Declining PGD: Accounts of Jewish Israeli Women Who Carry a BRCA1/2 Mutation or Partners of Male Mutation Carriers.

Authors:  Efrat Dagan; Daphna Birenbaum-Carmeli; Eitan Friedman; Baruch Feldman
Journal:  J Genet Couns       Date:  2017-03-06       Impact factor: 2.537

2.  Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome.

Authors:  Akriti Dewanwala; Anu Chittenden; Margery Rosenblatt; Rowena Mercado; Judy E Garber; Sapna Syngal; Elena M Stoffel
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

3.  Reproductive Decision-Making in Women with BRCA1/2 Mutations.

Authors:  Jessica L Chan; Lauren N C Johnson; Mary D Sammel; Laura DiGiovanni; Chan Voong; Susan M Domchek; Clarisa R Gracia
Journal:  J Genet Couns       Date:  2016-10-28       Impact factor: 2.537

4.  CLINICAL MANAGEMENT OF FAMILIES WITH HEREDITARY COLORECTAL CANCER SYNDROMES.

Authors:  Monica Dandapani; Elena M Stoffel
Journal:  Semin Colon Rectal Surg       Date:  2011-06-01

5.  Peutz-Jeghers syndrome and family planning: the attitude towards prenatal diagnosis and pre-implantation genetic diagnosis.

Authors:  Margot G F van Lier; Susanne E Korsse; Elisabeth M H Mathus-Vliegen; Ernst J Kuipers; Ans M W van den Ouweland; Kathleen Vanheusden; Monique E van Leerdam; Anja Wagner
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

6.  Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes.

Authors:  Thereasa A Rich; Mei Liu; Carol J Etzel; Sarah A Bannon; Maureen E Mork; Kaylene Ready; Devki S Saraiya; Elizabeth G Grubbs; Nancy D Perrier; Karen H Lu; Banu K Arun; Terri L Woodard; Leslie R Schover; Jennifer K Litton
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

7.  High-risk individuals' perceptions of reproductive genetic testing for CDH1 mutations.

Authors:  Nina Hallowell; Shirlene Badger; Sue Richardson; Carlos Caldas; Richard H Hardwick; Rebecca C Fitzgerald; Julia Lawton
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

8.  The Influence of Adolescence on Parents' Perspectives of Testing and Discussing Inherited Cancer Predisposition.

Authors:  Corinna L Schultz; Melissa A Alderfer; Robert B Lindell; Zachary McClain; Kristin Zelley; Kim E Nichols; Carol A Ford
Journal:  J Genet Couns       Date:  2018-06-16       Impact factor: 2.537

Review 9.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

10.  Clinical Utility Gene Card for: Familial adenomatous polyposis (FAP) and attenuated FAP (AFAP)--update 2014.

Authors:  Stefan Aretz; Hans F A Vasen; Sylviane Olschwang
Journal:  Eur J Hum Genet       Date:  2014-09-24       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.